Loading
Loading…
Loading…
| # | Company | Offered Item | Amount | Rank | Status |
|---|---|---|---|---|---|
| 1 | L1₹5.0 LQualified Make: AKURIT4
Model: AKURIT4
Title: AKURIT4 22 MUKERJEE MUKEERJI NAGAR DELHI DELHI 110009 | NORTH WEST DELHI | DELHI | 110009 | Make: AKURIT4
Model: AKURIT4
Title: AKURIT4 | L1 | Qualified MII | |
| 2 | L2₹5.0 L+₹4,040 (0.81%)Qualified Make: MORILLOXCINE 400
Model: AKURIT3
Title: AKURIT3 G1 N 2 CHETAN MEDICAL COMPLEX CHIPPI TANK OPP R G INTER COLLAGE MEERUT UTTAR PRADESH 250002 | MEERUT | UTTAR PRADESH | 250002 | Make: MORILLOXCINE 400
Model: AKURIT3
Title: AKURIT3 | L2 | Qualified MII | |
| 3 | L3₹5.0 L+₹4,393.50 (0.88%)Qualified Make: AKURIT4
Model: AKURIT3
Title: AKURIT3 H NO 1814 1 ST NO 15 DAULAT COLONY NEW MADHOPURI LUDHIANA PUNJAB 141007 | LUDHIANA | PUNJAB | 141007 | Make: AKURIT4
Model: AKURIT3
Title: AKURIT3 | L3 | Qualified MII |
Tender Value
₹5 L
EMD Value
Exempted
Closing Date
13 May 2024, 10:00 amClosed
FIRST LINE ANTI TB DRUG 4 NTEP (Q3)
6327861
GEM/2024/B/4875623
Two Packet Bid
FIRST LINE ANTI TB DRUG 4 NTEP
15 days
Haryana; Yamunanagar
Total value wise evaluation
PRODUCT_CUSTOM
3 documents required · 3 mandatory
1 yrs
₹3
10%
| Item | Delivery Location | Qty | Delivery |
|---|---|---|---|
| FIRST LINE ANTI TB DRUG 4 NTEP (Q3) | Vikas Sharma 135001,O/o Civil Surgeon | 5,050 | 15 days |
Exempted
14 May 2024
22 Apr 2024
13 May 2024
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_6327861.pdf
GEM_BID
report_gem_garpts_20042024_mzr1ys8yo05i_2024-04-20-01-08-21_96286758eb0e6bacb4ea91e769e513f5.pdf
SPECIFICATION
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .